Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include very common findings: Seborrheic dermatitis, Failure to thrive, Diarrhea, and Abnormality of immune system physiology.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 1 | Seborrheic dermatitis |
Growth and development |
Phenotype severity distribution: 4 very common features.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for erythroderma desquamativum.
2 publications have been identified in PubMed for erythroderma desquamativum. Research spans Review / Meta-Analysis (100%).
Martinez Salazar A (2025). [PMID: 40422242](https://pubmed.ncbi.nlm.nih.gov/40422242/). *Cells*. [Review / Meta-Analysis]
Chiriac A (2024). [PMID: 38845676](https://pubmed.ncbi.nlm.nih.gov/38845676/). *Indian Dermatol Online J*. [Review / Meta-Analysis]
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:13 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
1
Failure to thrive |
Digestive system | 1 | Diarrhea |
AI-curated news mentioning erythroderma desquamativum
Updated Jul 21, 2026
A recent study published in PubMed highlights a case of multicentric reticulohistiocytosis that progressed to erythroderma after long-term disease progression. This research adds to the understanding of disease progression in rare conditions.
A recent study highlights graft-versus-host disease-like erythroderma as a rare paraneoplastic disorder associated with thymoma. This discovery adds to the understanding of the complex interactions between tumors and immune responses.